Drug Resistant Tb

Diagnostic machines used for testing drug-resistant tuberculosis can now be used for screening and confirmation of COVID-19 cases, the apex health research body, ICMR, said.

Antibiotics that are currently in clinical development are insufficient to combat the growing threat of antimicrobial resistance, a World Health Organisation (WHO) report said.

New Delhi: About 8,000 patients pass through Dr Zarir F Udwadia’s busy clinic every year. The patients who are usually referred to him by colleagues from different parts of the country are difficult cases of multi-drug resistant tuberculosis (MDR-TB). An expert in drug-resistant tuberculosis and interstitial lung disease (ILD), Dr Udwadia is curr...

New Delhi: The government has introduced Tuberculosis tablets in orange and strawberry flavours for children who don’t take adequate dosage fearing it to be bitter. The initiative, that aims to improve the treatment of tuberculosis and child survival rate has been rolled out in five states and will be expanded to 17 more states by the next month....

A new study has found that India could witness an alarming spike in cases of drug-resistant tuberculosis in the next two decades.

Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...

The rise of multi-drug resistant (MDR) and extensively drug resistant tuberculosis is threatening to outdo years of progress in controlling the disease.

TB is treatable, however, the bacteria that cause TB can develop resistance to the antimicrobial drugs used to cure the disease. This is known as Drug-Resistant TB or Multidrug-resistant TB (MDR-TB).

Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...

New Delhi: A Patna teenager, who is suffering from extremely drug-resistant tuberculosis, has won her right to a necessary drug in court. But it would be at least another 16 days before she has it in her hand. The delay will be due to the lengthy administrative process, which her father Kaushal Kishore Tripathi is dealing with. The teenager who ha...

A teen’s court battle to gain urgent access to a new, government-controlled tuberculosis drug has become a rallying point for public health workers in India’s fight against a growing problem of drug-resistant diseases and attendant widespread health risks. The new drug, called bedaquiline, came to India last year, and it is now the only hope fo...

A centuries-old herbal Chinese medicine, used to effectively treat malaria, may help fight tuberculosis and slow the evolution of drug resistance, scientists have found.

A study based on a retrospective analysis of patient data at Sir Ganga Ram Hospital in New Delhi has revealed a 12 per cent increase in the incidence of multi-drug resistant tuberculosis (MDR-TB) in India between 2000 and 2012. Nearly 15,000 patients were subject to mycobacterial culture during the study.

Prescribing antibiotic doses once or twice a week for tuberculosis (TB) treatment are more likely to lead to drug resistant strains than daily antibiotic regimens, a computer model of the disease has shown.

As many as 1,000 people a day in Europe contract tuberculosis, and slow progress against the disease coupled with rising drug resistance mean the region is unlikely to defeat it until next century, health officials said today.

Diagnostic machines used for testing drug-resistant tuberculosis can now be used for screening and confirmation of COVID-19 cases, the apex health research body, ICMR, said.

Antibiotics that are currently in clinical development are insufficient to combat the growing threat of antimicrobial resistance, a World Health Organisation (WHO) report said.

New Delhi: About 8,000 patients pass through Dr Zarir F Udwadia’s busy clinic every year. The patients who are usually referred to him by colleagues from different parts of the country are difficult cases of multi-drug resistant tuberculosis (MDR-TB). An expert in drug-resistant tuberculosis and interstitial lung disease (ILD), Dr Udwadia is curr...

New Delhi: The government has introduced Tuberculosis tablets in orange and strawberry flavours for children who don’t take adequate dosage fearing it to be bitter. The initiative, that aims to improve the treatment of tuberculosis and child survival rate has been rolled out in five states and will be expanded to 17 more states by the next month....

A new study has found that India could witness an alarming spike in cases of drug-resistant tuberculosis in the next two decades.

Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...

The rise of multi-drug resistant (MDR) and extensively drug resistant tuberculosis is threatening to outdo years of progress in controlling the disease.

TB is treatable, however, the bacteria that cause TB can develop resistance to the antimicrobial drugs used to cure the disease. This is known as Drug-Resistant TB or Multidrug-resistant TB (MDR-TB).

Tuberculosis is one of the top 10 causes of death worldwide and India has the maximum number of cases of this deadly but curable and treatable disease. The World Health Organizations Global Tuberculosis Report in 2016 estimates that there are 79,000 cases of MDR-TB or Multi-Drug Resistance Tuberculosis. This is becoming a serious problem and a big ...

New Delhi: A Patna teenager, who is suffering from extremely drug-resistant tuberculosis, has won her right to a necessary drug in court. But it would be at least another 16 days before she has it in her hand. The delay will be due to the lengthy administrative process, which her father Kaushal Kishore Tripathi is dealing with. The teenager who ha...

A teen’s court battle to gain urgent access to a new, government-controlled tuberculosis drug has become a rallying point for public health workers in India’s fight against a growing problem of drug-resistant diseases and attendant widespread health risks. The new drug, called bedaquiline, came to India last year, and it is now the only hope fo...

A centuries-old herbal Chinese medicine, used to effectively treat malaria, may help fight tuberculosis and slow the evolution of drug resistance, scientists have found.

A study based on a retrospective analysis of patient data at Sir Ganga Ram Hospital in New Delhi has revealed a 12 per cent increase in the incidence of multi-drug resistant tuberculosis (MDR-TB) in India between 2000 and 2012. Nearly 15,000 patients were subject to mycobacterial culture during the study.

Prescribing antibiotic doses once or twice a week for tuberculosis (TB) treatment are more likely to lead to drug resistant strains than daily antibiotic regimens, a computer model of the disease has shown.

As many as 1,000 people a day in Europe contract tuberculosis, and slow progress against the disease coupled with rising drug resistance mean the region is unlikely to defeat it until next century, health officials said today.